Yes, I know Ibrutinib is mostly a US story - CLL Support

CLL Support

22,532 members38,709 posts

Yes, I know Ibrutinib is mostly a US story

andrewschorr profile image
1 Reply

My UK friend Nick has reminded me that the US FDA approval of ibrutinib is a nice thing there but has a long, long way to go to be accessible outside of a trial in many other places like the UK. I understand. But, that said, you might find of interest my blog about it as a step in the right direction: blog.patientpower.info/2014...

Written by
andrewschorr profile image
andrewschorr
To view profiles and participate in discussions please or .
Read more about...
1 Reply
Cllcanada profile image
CllcanadaTop Poster CURE Hero

I have received a number of emails asking when Imbruvica (ibrutinib) will be available in Canada. The answer is unknown.

Like everything in CLL watch & wait ...

Health Canada must approve the drug first, upon a request of the manufacture or supplier, which could be a lengthy process and can involve more clinical trials, then recommendations are made to the provinces for funding. The recommendations are just that, and provinces are not required to fund any particular drug... cost matters in the approval process.

To learn how cancer drugs are approved and funded here is a good booklet on the topic.

pcodr.ca/idc/groups/pcodr/d...

Quebec has their own funding process, separate from the process outlined in this document...

You may also like...

Trouble Getting Insurance Approval for Ibrutinib in the US?

Has anyone else had trouble getting Medicare (part D through WellCare) to approve their prescription

Ibrutinib my story update

local press in relation to being denied Ibrutinib for my relapsed CLL. On Friday last week I...

Success stories above 70 with Ibrutinib

mentioned before we will be probably going for Ibrutinib as agreed with the doctor already and I...

I am officially off of Ibrutinib

going to screw around and it meant the end of Ibrutinib after 8 months of attempting to take it...

Celebrating Five Years on PCI-32765, better know these days as Ibrutinib

International Workshop on CLL (iwCLL 2017). It was a great meeting and I saw many old CLL friends...